Source: Eur Respir J 2008; 32: 229-231
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Larsen, M. V., Sorensen, I. J., Thomsen, V. O., Ravn, P.. Re-activation of bovine tuberculosis in a patient treated with infliximab. Eur Respir J 2008; 32: 229-231

Member's Comments

No comment yet.

Related content which might interest you: Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis Source: Eur Respir J 2003; 21: 483-488 Year: 2003 Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis Source: Eur Respir J 2008; 32: 1607-1615 Year: 2008 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006 The levels of tumour necrosis factor-alpha and interleukin-1 in newly diagnosed and multi drug resistant tuberculosis Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis Year: 2004 Using an interferon-γ assay for the diagnosis of tuberculosis infection before using tumor necrosis factor-α blockers Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases Source: Eur Respir J 2009; 33: 586-593 Year: 2009 Pulmonary infection with Mycobacterium avium in immunocompetent children without IFN-γ (interferon-gamma) or IL-12-receptor deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010 Inhaled IFN-γ for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-γ deficiency Source: Eur Respir J 2004; 24: 367-370 Year: 2004 Changes in the quantity of 1b-interleukin (IL-1b), tumor necrosis factor-a (TNF-a) and interferon-g (IF-g) in evaluation of the effectiveness of treatment of tuberculosis by DOTS Source: Eur Respir J 2004; 24: Suppl. 48, 486s Year: 2004 Tumor necrosis factor alpha inhibitors and reactivation of tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 281s Year: 2007 Distinction tuberculosis from Mycobacterium avium complex disease using interferon-gamma release assay Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Serial interferon-gamma release assay in children with tuberculosis infection Source: Annual Congress 2010 - Tuberculosis in children Year: 2010 Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection Source: Eur Respir J 2013; 41: 644-648 Year: 2013 Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs Source: Eur Respir J 2009; 34: 702 Year: 2009